Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1055/a-1146-8674

http://scihub22266oqcxt.onion/10.1055/a-1146-8674
suck pdf from google scholar
32274773!7295266!32274773
unlimited free pdf from europmc32274773    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32274773 :   free
PDF vom PMID32274773  :  Publisher

suck abstract from ncbi

pmid32274773
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • SARS-CoV-2/COVID-19: Empfehlungen zu Diagnostik und Therapie #MMPMID32274773
  • Bein B; Bachmann M; Huggett S; Wegermann P
  • Anasthesiol Intensivmed Notfallmed Schmerzther 2020[Apr]; 55 (4): 257-265 PMID32274773show ga
  • COVID-19, a new viral disease affecting primarily the respiratory system and the lung, has caused a pandemic with serious challenges to health systems around the world. In about 20% of patients, severe symptoms occur after a mean incubation period of 5 - 6 days; 5% of patients need intensive care therapy. Morbidity is about 1 - 2%. Protecting health care workers is of paramount importance in order to prevent hospital acquired infections. Therefore, during all procedures associated with aerosol production, a personal safety equipment consisting of a FFP2/FFP3 (N95) respiratory mask, gloves, safety glasses and a waterproof overall should be used. Therapy is based on established recommendations issued for patients with acute lung injury (ARDS). Lung protective ventilation, prone position, restrictive fluid management and an adequate management of organ failures are the mainstays of therapy. In case of fulminant lung failure, veno-venous extracorporeal membrane oxygenation may be used as a rescue in experienced centres. New, experimental therapies evolve with ever increasing frequency; currently, however, there is no evidence based recommendation possible. If off-label and compassionate use of these drugs is considered, an individual benefit-risk assessment is necessary, since serious side effects have been reported.
  • |*Betacoronavirus[MESH]
  • |Coronavirus Infections/*diagnosis/*therapy[MESH]
  • |Evidence-Based Medicine[MESH]
  • |Extracorporeal Membrane Oxygenation/*methods[MESH]
  • |Humans[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*diagnosis/*therapy[MESH]
  • |Protective Clothing[MESH]
  • |Respiration, Artificial/methods[MESH]
  • |Risk Factors[MESH]
  • |Severity of Illness Index[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    257 4.55 2020